1. Esserman, L. J. et al. Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res. Treat. 129, 607–616 (2011).
2. Pan, H. et al. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N. Engl. J. Med. 377, 1836–1846 (2017).
3. Cancer Research UK. Breast cancer statistics. CRUK
http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer
(2018).
4. Dodson, A. et al. ER, PR and HER2 biomarkers in UK and Irish clinical breast cancer testing: analysis of results from>168,000 patients. Cancer Res. 78, (Suppl.), PR-08-16 (2017).
5. Cancer Research UK. Breast cancer incidence (invasive) statistics. CRUK
https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/incidence-invasive
(2018).